ATE129158T1 - Antikörper zu den aktivitätspromotoren eines kolonie stimulierenden faktors. - Google Patents

Antikörper zu den aktivitätspromotoren eines kolonie stimulierenden faktors.

Info

Publication number
ATE129158T1
ATE129158T1 AT90113097T AT90113097T ATE129158T1 AT E129158 T1 ATE129158 T1 AT E129158T1 AT 90113097 T AT90113097 T AT 90113097T AT 90113097 T AT90113097 T AT 90113097T AT E129158 T1 ATE129158 T1 AT E129158T1
Authority
AT
Austria
Prior art keywords
stimulating factor
coloney
antibodies
mip
myelopoietic
Prior art date
Application number
AT90113097T
Other languages
English (en)
Inventor
Stephen D Wolpe
Anthony Cerami
Barbara Sherry
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Application granted granted Critical
Publication of ATE129158T1 publication Critical patent/ATE129158T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
AT90113097T 1989-07-10 1990-07-09 Antikörper zu den aktivitätspromotoren eines kolonie stimulierenden faktors. ATE129158T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37793789A 1989-07-10 1989-07-10

Publications (1)

Publication Number Publication Date
ATE129158T1 true ATE129158T1 (de) 1995-11-15

Family

ID=23491090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90113097T ATE129158T1 (de) 1989-07-10 1990-07-09 Antikörper zu den aktivitätspromotoren eines kolonie stimulierenden faktors.

Country Status (12)

Country Link
EP (1) EP0409040B1 (de)
JP (1) JPH04501860A (de)
AT (1) ATE129158T1 (de)
AU (1) AU638473B2 (de)
CA (1) CA2035861A1 (de)
DE (1) DE69023060T2 (de)
DK (1) DK0409040T3 (de)
ES (1) ES2088925T3 (de)
GR (1) GR3018675T3 (de)
IE (1) IE72139B1 (de)
PT (1) PT94641A (de)
WO (1) WO1991000919A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145676A (en) * 1981-09-08 1992-09-08 The Rockefeller University Method and agents for promoting wound healing
US5154921A (en) * 1990-07-13 1992-10-13 Dana-Farber Cancer Institute, Inc. Promotion of maturation of hematopoietic progenitor cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58501544A (ja) * 1981-09-08 1983-09-16 ザ　ロツクフエラ−　ユニヴア−シテイ エンドトキシン誘発メディエ−タ−（ショック検定）によるリポプロティンリパ−ゼの抑圧
ATE149176T1 (de) * 1987-10-02 1997-03-15 Univ Rockefeller Von makrophagen abstammender entzündungsvermittler(mip-1-alpha et mip-1-beta)
DE68928124T2 (de) * 1988-09-02 1997-10-16 Chiron Corp., Emeryville, Calif. Makrophagenabgeleiteter entzündungsmediator(mip-2)

Also Published As

Publication number Publication date
EP0409040B1 (de) 1995-10-18
AU638473B2 (en) 1993-07-01
ES2088925T3 (es) 1996-10-01
JPH04501860A (ja) 1992-04-02
AU6040290A (en) 1991-02-06
DE69023060D1 (de) 1995-11-23
IE72139B1 (en) 1997-03-26
GR3018675T3 (en) 1996-04-30
WO1991000919A1 (en) 1991-01-24
EP0409040A1 (de) 1991-01-23
CA2035861A1 (en) 1991-01-11
DK0409040T3 (da) 1995-12-27
DE69023060T2 (de) 1996-04-18
PT94641A (pt) 1991-04-18

Similar Documents

Publication Publication Date Title
WO1992013553A3 (en) Method and agents for promoting wound healing
HUT77491A (hu) TIE-2 ligandumok, eljárás előállításukra és felhasználásuk
DK641889D0 (da) Anvendelse af en blodpladeaktiveringsfaktorantagonist i kombination med monoklonale eller polyklonale antistoffer i et farmaceutisk praeparat til behandling af endotoksisk chok hos pattedyr
DK0751992T3 (da) Karendotelvækstfaktor 2
DE69024369D1 (de) Latenz assoziierte peptide und deren verwendung
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
EP1734119A3 (de) CD16-II Variante
DE69034112D1 (de) Antikörper gegen Lymphozyten-assoziiertes Zelloberflächenprotein
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
HUP0003505A2 (hu) Aminoterminálisa felől csonkolt RANTES, mint kemokinantagonista
Seckinger et al. Tumor necrosis factor inhibitor: purification, NH2− terminal amino acidsequence and evidence for anti‐inflammatory and immunomodulatory activities
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
DE69023060D1 (de) Antikörper zu den Aktivitätspromotoren eines Kolonie stimulierenden Faktors.
JPH02500643A (ja) 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
FI883484A7 (fi) Bentsimidatsolijohdannaiset, niiden valmistus ja käyttö terapiassa.
Tokman et al. The pathogenesis of experimental toxic shock syndrome: the role of interleukin-2 in the induction of hypotension and release of cytokines
Potter et al. Separation and purification of lymphocyte chemotactic factor (LCF) and interleukin 2 produced by human peripheral blood mononuclear cells
ATE6639T1 (de) Ein gereinigtes polypeptid, ein verfahren zu dessen herstellung, dessen anwendung und das enthaltende pharmazeutische praeparat.
ATE180167T1 (de) Inhibition der ausscheidung von natrium durch die na-k-atpase
RU98111356A (ru) Способ лечения ожогового шока
Tokman Interleukin-2 (IL-2) and the Pathogenesis of Toxic Shock Syndrome Toxin-1 (TSST-1) Induced Hypotension
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
IT8420529A0 (it) N-acetil-s-acil-cisteina adattivita' terapeutica, procedimento per loro preparazione e loro uso in terapia.
ITMI922216A1 (it) Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee